iShares Health Innovation Active ETF Rating $24.82 +0.18 (+0.73%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsRatingsBuy This Stock iShares Health Innovation Active ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BMED Aggregate RatingModerate Buy 2.72Holdings in BMED have an aggregate rating of Moderate Buy based on 418 analyst ratings issued in the past year covering 20 companies (43.3% of the portfolio).BMED Aggregate Price Target$24.82High Prediction$24.82Average Prediction$24.82Low Prediction$24.82Holdings in BMED have an aggregate price target of $24.82 and a range of $24.82 to $24.82 covering 20 companies (43.3% of the portfolio).BMED Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Health Innovation Active ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 20 BMED Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.77%ABTAbbott Laboratories$134.41+1.8%4.9097 of 5 stars2.91$144.47 7.5%22Positive News3.63%MDTMedtronic$92.94+1.9%4.6214 of 5 stars2.59$98.19 5.6%22Positive News3.08%JNJJohnson & Johnson$173.40+1.1%4.6842 of 5 stars2.65$174.50 0.6%20Positive News3.06%EWEdwards Lifesciences$78.37+0.6%4.4919 of 5 stars2.65$85.90 9.6%26Analyst Forecast2.81%BSXBoston Scientific$103.22+0.3%4.5524 of 5 stars3.04$117.50 13.8%26Positive News2.31%PODDInsulet$307.10+1.2%4.309 of 5 stars2.84$324.72 5.7%19Trending NewsEarnings ReportAnalyst Forecast1.99%AAgilent Technologies$114.69+0.6%4.6863 of 5 stars2.54$139.77 21.9%13Positive News1.87%LHLabcorp$266.07+2.4%4.6613 of 5 stars2.62$289.58 8.8%13Positive News1.86%AMGNAmgen$288.23+1.2%4.5694 of 5 stars2.33$303.76 5.4%21Trending NewsEarnings ReportDividend AnnouncementAnalyst ForecastAnalyst Revision1.85%EXELExelixis$37.72+0.9%4.949 of 5 stars2.55$44.44 17.8%22Positive News1.81%IQVIQVIA$179.98+0.6%4.9032 of 5 stars2.74$228.62 27.0%23Positive News1.81%TMOThermo Fisher Scientific$461.34+1.5%4.9919 of 5 stars2.71$593.00 28.5%21Positive NewsInsider Trade1.75%BMYBristol Myers Squibb$45.96+1.3%4.6169 of 5 stars2.24$56.38 22.7%21Positive NewsAnalyst Downgrade1.71%EXASExact Sciences$40.99-5.0%4.7026 of 5 stars2.92$68.62 67.4%24Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionHigh Trading Volume1.71%ISRGIntuitive Surgical$470.08+0.1%4.9327 of 5 stars2.63$595.95 26.8%19Positive News1.67%NBIXNeurocrine Biosciences$125.01-0.5%4.9645 of 5 stars2.86$160.90 28.7%221.67%ABBVAbbVie$198.10-0.4%4.6841 of 5 stars2.93$214.43 8.2%27Trending NewsAnalyst UpgradeInsider Trade1.66%DXCMDexCom$78.86+3.2%4.9674 of 5 stars2.95$99.89 26.7%221.63%ILMNIllumina$94.56-1.0%4.8898 of 5 stars2.40$127.74 35.1%201.63%RYTMRhythm Pharmaceuticals$91.98-0.5%4.0819 of 5 stars3.07$101.57 10.4%15Earnings ReportAnalyst ForecastAnalyst Revision This page (NYSEARCA:BMED) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Health Innovation Active ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Health Innovation Active ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
